Laura Weller-Brophy was named biomedical product development and commercialization manager of Infotonics Technology Center (Cherry Hill, New Jersey). Brophy will focus her efforts on bringing to market optical diagnostic products being developed by BioScopix, a spin-off subsidiary of Mediscience Technology (Cherry Hill, New Jersey), in collaboration with equity partner Infotonics. The Infotonics Technology Center is a not-for-profit corporation that operates the state of New York’s Center of Excellence in Photonics and Microsystems.

Steven Owings has been named to the newly created position of VP of commercial development, Prenatal Diagnostics, at Sequenom (San Diego). Owings will lead commercialization of Sequenom’s non-invasive prenatal diagnostic technology now in development. The company said it expects application of its non-invasive technology for fetal Rhesus D (RhD) typing to become available first through a licensed clinical laboratory during the first half of this year. Sequenom says that Owings previously held managerial and sales positions at Roche Diagnostic Systems. Sequenom develops products that translate genomic science into solutions for biomedical research, molecular medicine, agricultural applications, and non-invasive prenatal testing.